Cambrex to Announce First Quarter 2018 Financial Results on May 3, 2018
April 26, 2018 15:15 ET
|
Cambrex Corporation
EAST RUTHERFORD, N.J., April 26, 2018 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE:CBM), a leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs),...
Cambrex Completes New $3.2 Million Analytical Research & Development Laboratory at its High Point, NC Facility
April 23, 2018 08:20 ET
|
Cambrex Corporation
EAST RUTHERFORD, N.J., April 23, 2018 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE:CBM), the leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs),...
Cambrex Corporation to Provide Additional Information Regarding its Environmental, Social and Governance Practices
April 19, 2018 16:30 ET
|
Cambrex Corporation
EAST RUTHERFORD, N.J., April 19, 2018 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE:CBM), a leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs),...
Cambrex Invests in New Continuous Flow Technology at its High Point, NC Facility
April 17, 2018 08:00 ET
|
Cambrex Corporation
EAST RUTHERFORD, N.J., April 17, 2018 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE:CBM), the leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs),...
Cambrex to Present at the 2018 RBC Capital Markets Global Healthcare Conference
February 15, 2018 08:00 ET
|
Cambrex Corporation
EAST RUTHERFORD, N.J., Feb. 15, 2018 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE:CBM), a leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs),...
Cambrex Reports Fourth Quarter and Full Year 2017 Financial Results
February 08, 2018 06:45 ET
|
Cambrex Corporation
- Net Revenue increased 2.5% for the fourth quarter and 9% for the full year 2017- - Conference call at 8:30 a.m. ET on February 8, 2018 - EAST RUTHERFORD, N.J., Feb. 08, 2018 (GLOBE NEWSWIRE)...
Cambrex to Announce Fourth Quarter and Full Year 2017 Financial Results on February 8, 2018
February 02, 2018 09:15 ET
|
Cambrex Corporation
EAST RUTHERFORD, N,J., Feb. 02, 2018 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE:CBM), a leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs),...
Cambrex Expands Process Research and Development Capabilities Across North America
January 30, 2018 08:00 ET
|
Cambrex Corporation
EAST RUTHERFORD, N.J., Jan. 30, 2018 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE:CBM), the leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs),...
Cambrex & AstraZeneca Hold Ceremony to Mark Long-Term Supply Agreement at Karlskoga, Sweden Facility
January 16, 2018 07:00 ET
|
Cambrex Corporation
EAST RUTHERFORD, N.J., Jan. 16, 2018 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE:CBM), the leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs),...
Cambrex Invests in New Small Scale Capacity at Its Charles City, Iowa Facility
November 08, 2017 08:00 ET
|
Cambrex Corporation
EAST RUTHERFORD, NJ, Nov. 08, 2017 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE:CBM), the leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs),...